Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
50.8M
-
Shares change
-
+2.53M
-
Total reported value, excl. options
-
$2.06B
-
Value change
-
+$106M
-
Put/Call ratio
-
1.59
-
Number of buys
-
70
-
Number of sells
-
-66
-
Price
-
$40.47
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q4 2021
163 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.8M shares
of 106M outstanding shares and own 48.09% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (5.52M shares), BlackRock Inc. (4.13M shares), PFM Health Sciences, LP (3.43M shares), VANGUARD GROUP INC (3.43M shares), BVF INC/IL (3.4M shares), FMR LLC (3.19M shares), Alphabet Inc. (2.56M shares), STATE STREET CORP (2.19M shares), Octagon Capital Advisors LP (2.1M shares), and Woodline Partners LP (1.71M shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.